Plain-English translation of NCT04359186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing what happens when people living with HIV pause their antiretroviral therapy (the medications that keep the virus under control). Researchers will take frequent blood samples before, during, and after the pause to understand how the virus rebounds and to identify early signals of rebound before it becomes detectable on standard tests.
Currently, doctors can only detect HIV rebound after the virus reaches a certain level in the bloodstream. By studying what happens at the very earliest stages of viral rebound, researchers hope to develop better ways to predict and prevent the virus from coming back, which could eventually lead to new strategies for treating HIV.
You likely qualify if…
You likely don't qualify if…
You would stop taking your HIV medication and come in for frequent blood tests to monitor what happens. Researchers will take intensive samples before you stop, while you're off medication, and after you restart. If your virus becomes detectable or after about three weeks (whichever comes first), you'll restart your medication. If you are a rare type of person whose immune system naturally controls HIV, you may be able to stay off medication longer with more flexible restart rules. Throughout, you'll receive counseling about preventing HIV transmission to sexual partners.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States
Sponsor
University of California, San Francisco
Collaborators
Chan Zuckerberg Biohub
Enrollment target
~40 participants
Started
October 2020
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Steven Deeks, MD
University of California, San Francisco
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.